Investment Rating - The report maintains a "Neutral" rating for Sinopec Engineering (02386) and lowers the target price by 6.25%, from HKD 8 to HKD 7.5 [1] Core Insights - Sinopec Engineering aims to achieve new orders of RMB 90 billion by 2026, with domestic orders at RMB 55 billion and overseas orders at USD 5 billion. This aligns with the view that domestic chemical demand has peaked [1] - For the fiscal year 2025, the company secured new orders of RMB 101 billion, with a record backlog of RMB 204 billion, of which overseas projects contributed 52%. However, the backlog turnover time has extended to 2.7 years, compared to the average of 2 years from 2018 to 2024, indicating prolonged execution cycles for overseas projects and a slowdown in domestic investment [1] - The forecast for the company's net profit after tax for 2026-2027 has been reduced by 3-4% due to the aforementioned factors [1] - The fiscal year 2025 saw a significant year-on-year decline of 27% in net profit after tax, which was much lower than expected, primarily due to a sharp drop in profit margins within the construction industry. Although management indicated that some projects are nearing completion, there is uncertainty regarding the recovery of short-term profit margins [1] - The company's dividend remained flat year-on-year [1]

Core Viewpoint - The recent updates from the company focus on the performance guidance for the fiscal year 2025 and operational status, with no new significant events announced [1]. Group 1: Performance and Operational Situation - The company reaffirmed its fiscal year 2025 performance guidance, projecting revenue between $4.65 billion and $4.85 billion, adjusted EBITDA guidance of $1.175 billion to $1.225 billion, and free cash flow expectations of $550 million to $600 million [2]. - The backlog of orders reached a record $5.14 billion in the first quarter of 2025, indicating robust demand for orders [2]. Group 2: Company Performance Goals - The company emphasized its mid-term development goals, including an organic revenue growth rate in the mid-teens, a gross margin level around 30%, and a target to reduce net leverage to a range of 2.0 to 2.5 times [3]. - The information is primarily sourced from public reports between March and May 2025, with no recent financial disclosures or future event plans announced as of February 11, 2026 [3].

Core Viewpoint - GE Vernova (NYSE: GEV) has shown exceptional performance in 2025 with a total return of approximately 99%, and its shares have increased nearly 10% in 2026 following a strong earnings report [2]. Financial Performance - The company reported Q4 2025 sales of just under $11 billion, reflecting a growth of 3.8%, surpassing estimates of $10.2 billion, which indicated a revenue decline of 3.4% [3]. - Earnings per share (EPS) reached $13.39, significantly exceeding estimates of $2.99, primarily due to a one-time $2.9 billion tax benefit [4]. Orders and Backlog - GE Vernova's orders surged to $22.2 billion, marking a 43% increase from $14.6 billion in the previous quarter [5]. - The company's backlog rose by $15 billion to a total of $150 billion, driven by strong demand in the Power and Electrification segments, which saw order increases of 50% and 45%, respectively [6]. Market Position and Valuation - Despite trading at a premium valuation compared to the overall market and the industrial sector, the company's strong demand and cash flow projections are noteworthy [3][6]. - The company's book-to-bill ratio of approximately 2x indicates that orders are being received at a pace that exceeds the company's ability to fulfill them, providing strong visibility into future sales growth [6][7].

Group 1 - The long-term outlook for Axon Enterprise is positive, with significant stock price appreciation following the second-quarter report [1][3] - Axon reported a 33% year-over-year revenue growth in Q2, reaching $669 million, marking the 14th consecutive quarter of growth exceeding 25% [4][5] - The company has a substantial market opportunity, with management targeting a $129 billion market, while currently generating $2.4 billion in trailing-12-month revenue [8] Group 2 - Future contracted bookings reached $10.7 billion, up 43% year-over-year, indicating strong future revenue growth potential [9][10] - Despite impressive growth, Axon's net income decreased by 12% in Q2 due to increased stock-based compensation, totaling $139 million for the quarter [11] - The stock trades at nearly 30 times sales, the highest valuation in two decades, necessitating continued robust growth to justify this valuation [15][16]